Amidopyrazole inhibitors of interleukin receptor-associated kinases
This invention relates to amidopyrazole compounds that are inhibitors of Interleukin receptor-associated kinases, in particular IRAK-4, and are useful in the treatment of cellular proliferative diseases, for example, cancer, hyperplasia, restenosis, cardiac hypertrophy, immune disorders and inflammation.
MERCK SHARP & DOHME CORP.
A A C
A61K A61P C07D
inventional inventional inventional
Ginny Dai Sunil Hua Joey L. William T. Liang William Michael Deen Zheng John Michael D. Guoqing
Ho Paliwal Zhou Methot McElroy Zhu Seganish Tulshian Tan Lampe Altman Li